Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
TradeZing
TradeZing
TradeZing
🔴 Live CPI Inflation Update Live Trading
Welcome to another enlightening episode on Michael Whitman’s channel, where we dive deep into the world of investing, spanning cryptocurrencies, stocks, and forex.
2 Day6 Hr16 Min2 Sec
YouTube
TradeZing
🔴PPI Data Extreme Bitcoin Volatility | Here’s What To Do
Welcome to another enlightening episode on Michael Whitman’s channel, where we dive deep into the world of investing, spanning cryptocurrencies, stocks, and forex.
3 Day6 Hr16 Min2 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
TZ PLUS Cash Back
Latest Feed
May 13, 2024
19 mins ago
Warner Music Group Corp. Announces Quarterly Cash Dividend
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group” or “WMG”) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.17 per share on WMG’s Class A Common Stock and Class B Common Stock. The dividend is payable on June 3, 2024, to stockholders of record as of the close of business on May 23, 2024.
179615
News
May 13, 2024
25 mins ago
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the initiation of a pilot program for its inFoods® IBS product with a large 1,100-member physician group. This pilot launch will commence in June 2024.
179616
News
May 13, 2024
29 mins ago
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Senti Bio today announced that patient dosing has commenced in the Phase 1 clinical trial of SENTI-202.
179617
News
Related on Reddit
Related on X
Related on YouTube
Can This High-Flying Stock 10x in 10 Years?
This midcap biotech could see huge success ahead — or disappointment.
Continue Reading
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 13, 2024
19 mins ago
Warner Music Group Corp. Announces Quarterly Cash Dividend
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group” or “WMG”) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.17 per share on WMG’s Class A Common Stock and Class B Common Stock. The dividend is payable on June 3, 2024, to stockholders of record as of the close of business on May 23, 2024.
WMG
179615
News
May 13, 2024
25 mins ago
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the initiation of a pilot program for its inFoods® IBS product with a large 1,100-member physician group. This pilot launch will commence in June 2024.
BMRA
179616
News
May 13, 2024
29 mins ago
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Senti Bio today announced that patient dosing has commenced in the Phase 1 clinical trial of SENTI-202.
SNTI
179617
News
Related on Reddit
Related on X
Related on YouTube
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
Can This High-Flying Stock 10x in 10 Years?
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments